Nishizawa Toshihiro, Sakitani Kosuke, Suzuki Hidekazu, Yoshida Shuntaro, Kataoka Yosuke, Nakai Yousuke, Ebinuma Hirotoshi, Kanai Takanori, Toyoshima Osamu, Koike Kazuhiko
Department of Gastroenterology, Toyoshima Endoscopy Clinic, Tokyo 1570066, Japan.
Department of Internal Medicine, Tokai University School of Medicine, Kanagawa 2591193, Japan.
World J Gastroenterol. 2020 Sep 21;26(35):5354-5361. doi: 10.3748/wjg.v26.i35.5354.
We have previously reported that ()-associated nodular gastritis could occur in both the antrum and the cardia. Cardiac nodularity-like appearance (hereafter, called as cardiac nodularity) had a high predictive accuracy for the diagnosis of infection. In the previous study, we included only the patients who were evaluated for infection for the first time, and excluded patients with a history of eradication. Therefore, the prevalence and clinical features of cardiac nodularity remains unknown.
To perform this cross-sectional study to explore the characteristics of cardiac nodularity.
Consecutive patients who underwent esophagogastroduodenoscopy between May, 2017 and August, 2019 in the Toyoshima Endoscopy Clinic were enrolled in this study. We included -negative, -positive, and -eradicated patients, and excluded patients with unclear status and eradication failure. infection was diagnosed according to serum anti- antibody and the urea breath test or histology. Cardiac nodularity was defined as a miliary nodular appearance or the presence of scattered whitish circular small colorations within 2 cm of the esophagogastric junction. Nodularity was visualized as whitish in the narrow-band imaging mode. We collected data on the patients' baseline characteristics.
A total of 1078 patients were finally included. Among -negative patients, cardiac nodularity and antral nodularity were recognized in 0.14% each. Among -positive patients, cardiac nodularity and antral nodularity were recognized in 54.5% and 29.5%, respectively. Among -eradicated patients, cardiac nodularity and antral nodularity were recognized in 4.5% and 0.6%, respectively. The frequency of cardiac nodularity was significantly higher than that of antral nodularity in -positive and -eradicated patients. The frequencies of cardiac nodularity and antral nodularity in -eradicated patients were significantly lower than those in -positive patients ( < 0.001). The patients with cardiac nodularity were significantly younger than those without cardiac nodularity ( = 0.0013). Intestinal metaplasia score of the patients with cardiac nodularity were significantly lower than those without cardiac nodularity ( = 0.0216). Among -eradicated patients, the patients with cardiac nodularity underwent eradication significantly more recently compared with those without cardiac nodularity ( < 0.0001).
This report outlines the prevalence and clinical features of cardiac nodularity, and confirm its close association with active infection.
我们之前报道过,()相关的结节性胃炎可发生于胃窦和贲门。贲门结节样外观(以下简称贲门结节)对感染的诊断具有较高的预测准确性。在之前的研究中,我们仅纳入了首次接受感染评估的患者,排除了有根除史的患者。因此,贲门结节的患病率和临床特征仍不清楚。
进行这项横断面研究以探讨贲门结节的特征。
纳入2017年5月至2019年8月在丰岛内镜诊所接受食管胃十二指肠镜检查的连续患者。我们纳入了阴性、阳性和根除患者,排除了感染状态不明和根除失败的患者。根据血清抗抗体、尿素呼气试验或组织学诊断感染。贲门结节定义为食管胃交界处2 cm范围内粟粒样结节外观或散在的白色圆形小色斑。在窄带成像模式下,结节呈白色。我们收集了患者的基线特征数据。
最终共纳入1078例患者。在阴性患者中,贲门结节和胃窦结节的检出率均为0.14%。在阳性患者中,贲门结节和胃窦结节的检出率分别为54.5%和29.5%。在根除患者中,贲门结节和胃窦结节的检出率分别为4.5%和0.6%。在阳性和根除患者中,贲门结节的发生率显著高于胃窦结节。根除患者中贲门结节和胃窦结节的发生率显著低于阳性患者(<0.001)。有贲门结节的患者比没有贲门结节的患者明显年轻(=0.0013)。有贲门结节的患者肠化生评分显著低于没有贲门结节的患者(=0.021)。在根除患者中,有贲门结节的患者与没有贲门结节的患者相比,根除时间明显更近(<0.0001)。
本报告概述了贲门结节的患病率和临床特征,并证实其与活动性感染密切相关。